CandlesenseCandlesense
ITRM•benzinga•

Iterum Gets Pfizer to Extend $20M Milestone Payment for ORLYNVAH Approval to 2029

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 19, 2025 by benzinga

← Back to ITRM News
    Iterum Gets Pfizer to Extend $20M Milestone Payment for ORLYNVAH Approval to 2029 | ITRM Stock News | Candlesense